National Health Investors, Inc. (NHI) Downgraded by Zacks Investment Research
National Health Investors, Inc. (NYSE:NHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
Other research analysts have also recently issued research reports about the company. BidaskClub cut National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Mizuho reaffirmed a “neutral” rating on shares of National Health Investors in a research report on Wednesday, June 28th. Stifel Nicolaus upped their price target on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. ValuEngine cut National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Finally, Bank of America Corporation cut National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price target on the stock. in a research report on Monday, May 22nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. National Health Investors presently has an average rating of “Hold” and an average price target of $80.50.
National Health Investors (NHI) traded up 0.13% on Thursday, reaching $79.99. The company’s stock had a trading volume of 386,518 shares. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 20.54 and a beta of 0.56. The firm has a 50 day moving average of $78.56 and a 200 day moving average of $75.95. National Health Investors has a 12 month low of $66.31 and a 12 month high of $81.29.
National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm had revenue of $69.84 million for the quarter, compared to analysts’ expectations of $67.68 million. During the same period in the prior year, the company earned $1.22 EPS. The firm’s quarterly revenue was up 14.1% on a year-over-year basis. Analysts anticipate that National Health Investors will post $3.85 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “National Health Investors, Inc. (NHI) Downgraded by Zacks Investment Research” was first published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/09/17/national-health-investors-inc-nhi-downgraded-by-zacks-investment-research.html.
In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the sale, the insider now owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 5.19% of the company’s stock.
A number of institutional investors and hedge funds have recently modified their holdings of NHI. Carroll Financial Associates Inc. purchased a new stake in National Health Investors during the 2nd quarter worth about $158,000. Quantbot Technologies LP purchased a new stake in National Health Investors during the 1st quarter worth about $201,000. Yorktown Management & Research Co Inc purchased a new stake in National Health Investors during the 2nd quarter worth about $214,000. Allegis Investment Advisors LLC purchased a new stake in National Health Investors during the 2nd quarter worth about $216,000. Finally, Daiwa Securities Group Inc. lifted its holdings in National Health Investors by 1.7% during the 1st quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock worth $232,000 after purchasing an additional 55 shares in the last quarter. 70.58% of the stock is currently owned by institutional investors and hedge funds.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.